FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernd Kasper

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Bernd Kasper; Monia Ouali; Jean-Yves Blay; Vivien H C Bramwell; Peter Hohenberger; Martine Van Glabbeke; Penella J Woll; Patrick Schöffski
Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Philipp Erben; Ralf-Dieter Hofheinz; Wolf-Karsten Hofmann; Peter Hohenberger; Daniel Nowak; Christian Sauer; Philipp Ströbel; Bernd Kasper
Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesions.
Bernd Kasper; Peter Hohenberger
Pazopanib: a promising new agent in the treatment of soft tissue sarcomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernd Kasper (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bernd Kasper; Monia Ouali; Jean-Yves Blay; Vivien H C Bramwell; Peter Hohenberger; Martine Van Glabbeke; Penella J Woll; Patrick Schöffski
Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
European journal of cancer (Oxford, England : 1990) 2013;49(2):449-56.
2012: Philipp Erben; Ralf-Dieter Hofheinz; Wolf-Karsten Hofmann; Peter Hohenberger; Daniel Nowak; Christian Sauer; Philipp Ströbel; Bernd Kasper
Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesions.
Onkologie 2012;35(11):684-9.
2011: Bernd Kasper; Peter Hohenberger
Pazopanib: a promising new agent in the treatment of soft tissue sarcomas.
Future oncology (London, England) 2011;7(12):1373-83.
2011: Bernd Kasper; Philipp Ströbel; Peter Hohenberger
Desmoid tumors: clinical features and treatment options for advanced disease.
The oncologist 2011;16(5):682-93.
2010: Bernd Kasper; Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Peter Hohenberger
Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib.
European journal of nuclear medicine and molecular imaging 2010;37(10):1876-82.
2010: Bernd Kasper; I Scharrenbroich; T Schmitt; P Wuchter; S Dietrich; Anthony Ho; Gerlinde Egerer
Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study.
Bone marrow transplantation 2010;45(7):1234-8.
2010: Susanne Jung; Bernd Kasper
Palifosfamide, a bifunctional alkylator for the treatment of sarcomas.
IDrugs : the investigational drugs journal 2010;13(1):38-48.
2009: Thomas Schmitt; Bernd Kasper
New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma.
Expert review of anticancer therapy 2009;9(8):1159-67.
2009: Bernd Kasper; Thomas Schmitt; Patrick Wuchter; Antonia Dimitrakopoulou-Strauss; Anthony D Ho; Gerlinde Egerer
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
Marine drugs 2009;7(3):331-40.
2008: Sebastian Belle; Fang Han; Maud Condomines; Olaf Christensen; Mathias Witzens-Harig; Bernd Kasper; Christian Kleist; Peter Terness; Marion Moos; Friedrich W Cremer; Dirk Hose; Anthony Ho; Hartmut Goldschmidt; Bernard Klein; Michael Hundemer
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.
European journal of haematology 2008;81(1):26-35.
2008: Bernd Kasper; Sascha Dietrich; Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Uwe Haberkorn; Anthony Ho; Gerlinde Egerer
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Onkologie 2008;31(3):107-12.
2007: Bernd Kasper
Standards and novel therapeutic options in the treatment of patients with soft tissue sarcoma.
Reviews on recent clinical trials 2007;2(3):206-11.
2007: Bernd Kasper; Thierry Gil; Ahmad Awada
Treatment of patients with advanced soft tissue sarcoma: disappointment or challenge?
Current opinion in oncology 2007;19(4):336-40.
2007: Bernd Kasper; Gerlinde Egerer; Martina Gronkowski; Sabine Haufe; Thomas Lehnert; Michael Eisenhut; Gunhild Mechtersheimer; Anthony Ho; Uwe Haberkorn
Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET.
Leukemia & lymphoma 2007;48(4):746-53.
2007: Bernd Kasper; Veronique D'Hondt; Pierre Vereecken; Ahmad Awada
Novel treatment strategies for malignant melanoma: a new beginning?
Critical reviews in oncology/hematology 2007;62(1):16-22.
2007: Bernd Kasper; Thierry Gil; Veronique D'Hondt; Michael Gebhart; Ahmad Awada
Novel treatment strategies for soft tissue sarcoma.
Critical reviews in oncology/hematology 2007;62(1):9-15.
2007: Bernd Kasper; Sascha Dietrich; Gunhild Mechtersheimer; Anthony Ho; Gerlinde Egerer
Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients.
Oncology 2007;73(1-2):58-64.
2006: Bernd Kasper; Dominique Lossignol; Thierry Gil; Patrick Flamen; Nicolas de Saint-Aubain; Ahmad Awada
Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.
Anti-cancer drugs 2006;17(10):1223-5.
2006: Thomas Hess; Gerlinde Egerer; Bernd Kasper; KAKIL RASUL; Hartmut Goldschmidt; G W Kauffmann
Atypical manifestations of multiple myeloma: radiological appearance.
European journal of radiology 2006;58(2):280-5.
2006: Bernd Kasper; Anthony Ho; Gerlinde Egerer
Dose-intensive chemotherapy with stem cell support as a treatment strategy for bone and soft-tissue sarcomas.
Current stem cell research & therapy 2006;1(1):29-35.
2006: Bernd Kasper; Birgit Kallinowski; Thomas Herrmann; Thomas Lehnert; Gunhild Mechtersheimer; Thomas Geer; Anthony Ho; Gerlinde Egerer
Treatment of gastrointestinal stromal tumor with imatinib mesylate: a retrospective single-center experience in Heidelberg.
Digestive diseases (Basel, Switzerland) 2006;24(1-2):207-11.
2005: Bernd Kasper; Anthony Ho; Gerlinde Egerer
A new therapeutic approach in patients with advanced sarcoma.
International journal of clinical oncology 2005;10(6):438-40.
2005: Bernd Kasper; Anthony Ho; Gerlinde Egerer
Is there an indication for high-dose chemotherapy in the treatment of bone and soft-tissue sarcoma?
Oncology 2005;68(2-3):115-21.
2004: Bernd Kasper; Thomas Lehnert; Ludger Bernd; Gunhild Mechtersheimer; Hartmut Goldschmidt; Anthony Ho; Gerlinde Egerer
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas.
Bone marrow transplantation 2004;34(1):37-41.
2004: Bernd Kasper; Christoph Harter; Julia Meissner; Frauke Bellos; Fatime Krasniqi; Anthony Ho; Gerlinde Egerer
Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(3):205-7.